In 2023, there were over 2,100 ongoing oncologic trials in phases 1 to 3. Based on mechanisms of action, PD-1/PD-L1 inhibitors had a share of 16 percent among therapies. This statistic shows the share of clinical drug trials in the oncology pipeline worldwide, by mechanism of action.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
EFPIA, & IQVIA. (December 9, 2024). Share of clinical trials in the oncology pipeline worldwide in 2023, by mechanism of action [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 24, 2026, from /statistics/1249138/oncology-pipeline-by-key-technologies-worldwide/
EFPIA, und IQVIA. "Share of clinical trials in the oncology pipeline worldwide in 2023, by mechanism of action." Chart. December 9, 2024. ÌÇÐÄÆƽâ°æ. Accessed July 24, 2026. /statistics/1249138/oncology-pipeline-by-key-technologies-worldwide/
EFPIA, IQVIA. (2024). Share of clinical trials in the oncology pipeline worldwide in 2023, by mechanism of action. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 24, 2026. /statistics/1249138/oncology-pipeline-by-key-technologies-worldwide/
EFPIA, and IQVIA. "Share of Clinical Trials in The Oncology Pipeline Worldwide in 2023, by Mechanism of Action." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 9 Dec 2024, /statistics/1249138/oncology-pipeline-by-key-technologies-worldwide/
EFPIA & IQVIA, Share of clinical trials in the oncology pipeline worldwide in 2023, by mechanism of action ÌÇÐÄÆƽâ°æ, /statistics/1249138/oncology-pipeline-by-key-technologies-worldwide/ (last visited July 24, 2026)
Share of clinical trials in the oncology pipeline worldwide in 2023, by mechanism of action [Graph], EFPIA, & IQVIA, December 9, 2024. [Online]. Available: /statistics/1249138/oncology-pipeline-by-key-technologies-worldwide/
